Biomarkers | European Cystic Fibrosis Society (ECFS)

Kaftrio® quickly modifies the composition of breath in children with CF.

Making the diagnosis of nontuberculous mycobacteria (NTM) lung disease standard with the PREDICT study

Breakdown of lung proteins causes structural damage in cystic fibrosis lungs

High blood eosinophil counts are linked with worse symptoms in adults with cystic fibrosis

A Short extension to multiple breath washout provides additional indications of blocked and severely diseased airways in people with CF: a pilot study

Evaluation of airway and circulating inflammatory biomarkers for cystic fibrosis drug development

Circulating CRP and calprotectin to diagnose CF pulmonary exacerbations

Utilizing centralized biorepository samples for biomarkers of cystic fibrosis lung disease severity

Blood Biomarkers to Predict Short-term Pulmonary Exacerbation Risk in Children and Adolescents with CF: A Pilot Study

Urinary Metabolomics Reveals Unique Metabolic Signatures in Infants with Cystic Fibrosis

1
2
next
last